Life science buildings comprise nearly one-third of the office development pipeline today, according to Yardi's Commercial Edge.
This, despite a reduction in venture capital funding in 2023 due to rising interest rates, the collapse of Silicon Valley Bank, and general economic uncertainty.
While the first half of 2023 saw the lowest amount of VC funding since 2019, investment this year will surpass any year before 2018, according to Commercial Edge's National Office Report for August.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
